Sorry, no results.
Please try another keyword
- no143https://dts.podtrac.com/redirect.mp3/traffic.libsyn.com/secure/hiddenforces/Ep.143_Vivian_Lee_Regular_Episode_6-29-20.mp3https://hiddenforces.io/wp-content/uploads/securepdfs/2022/02/HFT_PREMIUM_EP_143.pdfhttps://hiddenforces.io/wp-content/uploads/securepdfs/2022/02/HF_RD_143.pdfVivian S. LeeVivian S. Lee, M.D., Ph.D., M.B.A, is President of Health Platforms at Verily Life Sciences, an Alphabet company whose mission is to apply digital solutions that enable people enjoy healthier lives. A passionate champion of improving health in the U.S. and worldwide, she works closely with Verily’s clinical and engineering teams to develop products and platforms that support the successful transformation of health systems to value and advance the co-production of health with patients, their caregivers, and communities. She also serves as a Senior Lecturer at Harvard Medical School and Massachusetts General Hospital, and a Senior Fellow at the Institute for Healthcare Improvement. In 2019, she was ranked #11 among the Most Influential People in Healthcare (Modern Healthcare). Dr. Lee is the former Dean, SVP and CEO University of Utah Health. As a leading healthcare executive, she is committed to the advancement of value-driven transformation in health care (NYT Corner Office, STAT). As CEO, Lee led University of Utah Health to recognition for its health care delivery system innovations (Algorithmsforinnovation.org) that enable higher quality at lower costs (JAMA & editorial, NYT) and with higher patient satisfaction (NYT, HBR, NEJM), as well as successful strategies of faculty development and mentorship. In 2016, University of Utah was ranked first among the nation’s university hospitals in quality and safety (Vizient). The University’s health plan grew five-fold and was successful in the individual exchange. As Dean, she led the significant expansion of the School of Medicine class size with increased state funding, and helped raise large philanthropic gifts. Lee is an MR radiologist who developed novel methods for measuring kidney function and vascular disease with MRI. Funded by the NIH for 20 years, Dr. Lee was elected to National Academy of Medicine (formerly, the Institute of Medicine) in 2015, and in 2019, she received the International Society for Magnetic Resonance in Medicine’s highest award for scientific contributions and leadership, the Gold Medal. She served on the NIH Council of Councils advisory to the NIH Director and has authored over 200 peer-reviewed research publications. Presently she serves on the Defense Health Board, advisory to the Department of Defense for military medicine, the Board of Directors of the Commonwealth Fund and the Association of American Rhodes Scholars, the Membership Committee of the National Academy of Medicine, and on the Scientific Advisory Board of the Massachusetts General Hospital. She is also a director on the board of Zions Bancorporation, a publicly traded company. Dr. Lee is a magna cum laude graduate of Harvard-Radcliffe Colleges, received a doctorate in medical engineering from Oxford University as a Rhodes Scholar, earned her M.D. with honors from Harvard Medical School, and was valedictorian of her Executive MBA program at NYU’s Stern School of Business.58930no